These findings suggest that Tau hyperphosphorylation, a well-known hallmark of AD, might be also indicated as an age-related target in healthy subjects, as already reported (Noble et al., 2013; Carlyle et al., 2014). Here, MAPT is linked to Alzheimer disease.